Literature DB >> 26649732

Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior.

Masaaki Sugimoto1, Kenichi Kohashi1, Kentaro Kuroiwa2, Tatsuro Abe1, Yuichi Yamada1, Masaki Shiota2, Kenjiro Imada2, Seiji Naito3, Yoshinao Oda4.   

Abstract

In renal cell carcinoma (RCC), tumor cells with rhabdoid features are characterized by eccentric nuclei, prominent nucleoli, and eosinophilic cytoplasm with intracytoplasmic inclusion bodies. In RCC, tumor cells have also been observed resembling rhabdomyoblasts or rhabdoid but without intracytoplasmic inclusion bodies, and here, we defined these rhabdoid-like features of these cells. To this end, we studied a series of clear cell RCC (ccRCC) with rhabdoid features and compared them with a series of ccRCC with rhabdoid-like features to clarify the differences in the immunohistochemical profile and biological behavior. From 695 cases of ccRCC (80.8 % of all RCCs), 18 cases with rhabdoid features (2.1 % of all RCCs) and 25 cases with rhabdoid-like features (2.9 % of all RCCs) were investigated. The 5-year survival rate for ccRCC with rhabdoid features was 44.7 % and for ccRCC with rhabdoid-like features 30.3 %. Although ccRCC with rhabdoid features showed immunohistochemical co-expression of epithelial markers and vimentin as seen in malignant rhabdoid tumors, ccRCC with rhabdoid-like features showed no such co-expression. Multivariate analyses of cancer-specific survival revealed that perinephric tissues invasion was an independent prognostic factor in ccRCC with rhabdoid features (p = 0.0253) but not in ccRCC with rhabdoid-like features. In summary, although their prognosis is similar, the marker profile and pattern of extension of ccRCC with rhabdoid-like is different from that of ccRCC with rhabdoid features. Therefore, ccRCC with rhabdoid-like features should be distinguished from ccRCC with rhabdoid features.

Entities:  

Keywords:  Intracytoplasmic inclusion body; Renal cell carcinoma; Rhabdoid features; Rhabdoid-like features

Mesh:

Substances:

Year:  2015        PMID: 26649732     DOI: 10.1007/s00428-015-1885-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

1.  Renal cell carcinoma with rhabdoid features: an aggressive neoplasm.

Authors:  K Kuroiwa; Y Kinoshita; H Shiratsuchi; Y Oshiro; S Tamiya; Y Oda; S Naito; M Tsuneyoshi
Journal:  Histopathology       Date:  2002-12       Impact factor: 5.087

2.  Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53.

Authors:  Xavier Leroy; Laurent Zini; David Buob; Charles Ballereau; Arnauld Villers; Sebastien Aubert
Journal:  Arch Pathol Lab Med       Date:  2007-01       Impact factor: 5.534

Review 3.  SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.

Authors:  Abbas Agaimy; Tilman T Rau; Arndt Hartmann; Robert Stoehr
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

4.  Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.

Authors:  Isidro Machado; María Victoria López-Soto; Luis Rubio; Lara Navarro; Antonio Llombart-Bosch
Journal:  Diagn Cytopathol       Date:  2015-02-19       Impact factor: 1.582

Review 5.  Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.

Authors:  Natasha Savage; Dan Linn; Colleen McDonough; Jeffrey M Donohoe; Arie Franco; Victor Reuter; Paul W Biddinger; Katherine W Eaton; Jaclyn A Biegel; Suash Sharma
Journal:  Ann Diagn Pathol       Date:  2011-07-19       Impact factor: 2.090

Review 6.  Chromophobe renal cell carcinoma with rhabdoid differentiation in an adult.

Authors:  Iva Brčić; Borislav Spajić; Božo Krušlin
Journal:  Wien Klin Wochenschr       Date:  2012-06-14       Impact factor: 1.704

7.  Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.

Authors:  Matthias Waldert; Andrea Haitel; Michael Marberger; Daniela Katzenbeisser; Mehmet Ozsoy; Elisabeth Stadler; Mesut Remzi
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

8.  Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.

Authors:  Sandra Steffens; Frederik C Roos; Martin Janssen; Frank Becker; Julie Steinestel; Mahmoud Abbas; Konrad Steinestel; Gerd Wegener; Stefan Siemer; Joachim W Thüroff; Rainer Hofmann; Michael Stöckle; Mark Schrader; Arndt Hartmann; Kerstin Junker; Markus A Kuczyk; Andres J Schrader
Journal:  Virchows Arch       Date:  2014-09-02       Impact factor: 4.064

9.  Collecting duct carcinoma exhibiting diastase-resistant PAS-positive globular cytoplasmic inclusions and rhabdoid features arising in adult polycystic kidney disease: a case report.

Authors:  Naoto Kuroda; Hirofumi Satake; Eriko Miyazaki; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan
Journal:  Int J Surg Pathol       Date:  2004-04       Impact factor: 1.271

10.  Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.

Authors:  Patrick E Teloken; R Houston Thompson; Satish K Tickoo; Angel Cronin; Caroline Savage; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.